Trump election sends aftershocks through biotech sector

[el-text]

ADVI’s CEO Marc Samuels was interviewed about the new Trump Administration and various healthcare issues including reform of drug pricing. To learn more about the President Elect and our view of the impact of the new Congress and President write to us at hello@advi.com

[/el-text]

[el-text]

[/el-text]